Temozolomide

NDC 82249-408 · CivicaScript LLC

Generic nameTemozolomide

Dosage formCAPSULE

RouteORAL

Active ingredient(s)TEMOZOLOMIDE

Strength100 mg/1

Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]

Marketing categoryANDA

Packages

82249-408-05 — 5 CAPSULE in 1 BOTTLE (82249-408-05)

82249-408-14 — 14 CAPSULE in 1 BOTTLE (82249-408-14)

FDA lists these products with the same active ingredient.

72162-2662 — Temozolomide, 72162-2663 — Temozolomide, 72162-2664 — Temozolomide, 73043-011 — Temozolomide, 73043-012 — Temozolomide, 73043-013 — Temozolomide, 73043-014 — Temozolomide, 73043-015 — Temozolomide, 73043-016 — Temozolomide, 75834-132 — temozolomide, 75834-142 — temozolomide, 75834-143 — temozolomide, 75834-144 — temozolomide, 75834-145 — temozolomide, 75834-146 — temozolomide, 82249-404 — Temozolomide, 82249-406 — Temozolomide, 82249-410 — Temozolomide, 82249-412 — Temozolomide, 82249-414 — Temozolomide, +50 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.